[Management of acute coronary syndrome without ST-segment elevation]
Maria Rubini Gimenez1, Holger Thiele1, Janine Pöss2
1Klinik für Innere Medizin/Kardiologie, Herzzentrum Leipzig - Universität Leipzig, Strümpellstr. 39, 04289, Leipzig, Deutschland.
Insights
Acute coronary syndrome (ACS) includes STEMI and NSTE-ACS. New guidelines focus on high-sensitivity cardiac troponin assays for rapid diagnosis and triage of NSTE-ACS in emergency settings.
Area of Science:
- Cardiology
- Emergency Medicine
Background:
- Acute coronary syndrome (ACS) is a spectrum of conditions including ST-segment elevation myocardial infarction (STEMI) and non-ST-segment elevation ACS (NSTE-ACS).
- NSTE-ACS, encompassing unstable angina and NSTEMI, presents diagnostic and management challenges compared to STEMI.
Purpose of the Study:
- To summarize the 2020 European Society of Cardiology (ESC) guidelines for the diagnosis and management of NSTE-ACS.
- To highlight the role of high-sensitivity cardiac troponin assays (hs-cTn) in NSTE-ACS triage.
Main Methods:
- Review of the 2020 ESC guidelines for NSTE-ACS treatment.
- Focus on diagnostic algorithms utilizing hs-cTn assays for rapid rule-in or rule-out of NSTEMI.
Main Results:
- Guidelines cover diagnostics, risk stratification, antithrombotic therapy, coronary diagnostics, and long-term management of NSTE-ACS.
- hs-cTn assays combined with validated algorithms facilitate quick triage decisions in emergency departments and chest pain units.
Conclusions:
- The 2020 ESC guidelines provide a comprehensive framework for NSTE-ACS management.
- Effective utilization of hs-cTn assays is crucial for efficient NSTE-ACS diagnosis and patient stratification.
Abstract:
The collective term acute coronary syndrome (ACS) encompasses ST-segment elevation myocardial infarction (STEMI) and non-ST-segment elevation ACS (NSTE-ACS). The latter comprises unstable angina pectoris and non-ST-segment elevation myocardial infarction (NSTEMI). The diagnosis of STEMI necessitates an immediate referral to cardiac catheterization. The diagnostics and management of NSTE-ACS are more challenging. The current guidelines of the European Society of Cardiology (ESC) for treatment of NSTE-ACS were published in 2020 and deal with the topics of diagnostics, risk stratification, antithrombotic treatment, invasive or non-invasive coronary diagnostics and long-term treatment. The focus of the guidelines is on the application of high-sensitivity cardiac troponin assay(hs-cTn) combined with verified diagnostic algorithms to enable a rapid triage decision (rule-in as possible NSTEMI or rule-out as NSTEMI excluded) in the emergency room or the chest pain unit.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome V: Nursing Management
Angina IV: Management
Acute Coronary Syndrome III: Diagnostic Studies


